chondrocelect
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2002 (NCT00414700)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- ChondrocyteSupplementation
Chondrocyte supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cci
- characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
- chondrocelect
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00414700 | Phase 3 | Feb 1, 2002 | Katholieke Universiteit Leuven, TiGenix, Utrecht University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2002 |
| TiGenix | For profit | 1 | 1 | 1 | 2002 |
| Utrecht University | Academic/Hospital | 1 | 0 | 1 | 2002 |
3 organizations
Page 1 / 1